CD69 and acute myeloid leukemia: These results were further supported by our analysis of two large public AML cohorts, which showed that the presence of a high percentage of CD69+ HSC-like cells (CD69+-high) was associated with significantly higher rates of MRD positivity and relapse, as well as decreased survival rates (Fig. 7e, h and Additional file 1: Fig. S9e, f).